From this presentation, one will learn:

  • Characteristics of DCTs and hybrid trials and how these differ from virtual trials
  • A spectrum of approaches to DCTs, how they help patients, and the impact of the pandemic on adoption of remote approaches
  • About SDR and how it aligns with risk-based monitoring and differs from source data verification (SDV)
  • How a systems approach to clinical research and standards can support DCTs
  • Opportunities to leverage eSource technology and a clinical control layer to actualize DCTs and SDR